FDA — authorised 22 December 2015
- Marketing authorisation holder: ARDEA BIOSCIENCES INC
- Status: approved
FDA authorised Zurampic on 22 December 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 December 2015.
ARDEA BIOSCIENCES INC holds the US marketing authorisation.